Latest Stories
MGP Ingredients (MGPI): Buy, Sell, or Hold Post Q3 Earnings?
Over the last six months, MGP Ingredients’s shares have sunk to $25.87, producing a disappointing 6.6% loss - a stark contrast to the S&P 500’s 8.4% gain. This may have investors wondering how to approach the situation.
Spotting Winners: Merit Medical Systems (NASDAQ:MMSI) And Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks In Q3
Let’s dig into the relative performance of Merit Medical Systems (NASDAQ:MMSI) and its peers as we unravel the now-completed Q3 medical devices & supplies - cardiology, neurology, vascular earnings season.
Q3 Earnings Highlights: Wingstop (NASDAQ:WING) Vs The Rest Of The Modern Fast Food Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Wingstop (NASDAQ:WING) and its peers.
Q3 Earnings Outperformers: JLL (NYSE:JLL) And The Rest Of The Real Estate Services Stocks
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the real estate services industry, including JLL (NYSE:JLL) and its peers.
Winners And Losers Of Q4: Forestar Group (NYSE:FOR) Vs The Rest Of The Consumer Discretionary Stocks
Let’s dig into the relative performance of Forestar Group (NYSE:FOR) and its peers as we unravel the now-completed Q4 consumer discretionary earnings season.
Q3 Earnings Roundup: Clear Channel Outdoor (NYSE:CCO) And The Rest Of The Advertising & Marketing Services Segment
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how advertising & marketing services stocks fared in Q3, starting with Clear Channel Outdoor (NYSE:CCO).
Monolithic Power Systems (NASDAQ:MPWR) Q4: Beats On Revenue But Inventory Levels Increase
Power management chips maker Monolithic Power Systems (NASDAQ:MPWR) reported revenue ahead of Wall Streets expectations in Q4 CY2025, with sales up 20.8% year on year to $751.2 million. On top of that, next quarter’s revenue guidance ($780 million at the midpoint) was surprisingly good and 5.7% above what analysts were expecting. Its non-GAAP profit of $4.79 per share was 1.1% above analysts’ consensus estimates.
CNO Financial Group (NYSE:CNO) Posts Better-Than-Expected Sales In Q4 CY2025
Insurance services company CNO Financial Group (NYSE:CNO) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 15.5% year on year to $1.14 billion. Its GAAP profit of $0.95 per share was 16.8% below analysts’ consensus estimates.
Encompass Health (NYSE:EHC) Reports Q4 CY2025 In Line With Expectations, Stock Jumps 17.5%
Health care services provider Encompass Health (NYSE:EHC) met Wall Streets revenue expectations in Q4 CY2025, with sales up 9.9% year on year to $1.54 billion. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $6.42 billion at the midpoint. Its non-GAAP profit of $1.46 per share was 12.1% above analysts’ consensus estimates.
ENSG Q4 Deep Dive: Acquisition Activity and Clinical Specialization Drive Outlook
Healthcare services company The Ensign Group (NASDAQ:ENSG). fell short of the market’s revenue expectations in Q4 CY2025, but sales rose 31.5% year on year to $1.49 billion. On the other hand, the company’s full-year revenue guidance of $5.81 billion at the midpoint came in 1.6% above analysts’ estimates. Its GAAP profit of $1.61 per share was 3.3% below analysts’ consensus estimates.